The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I
Open accessAbstract
Metformin and thiazolidinediones (TZDs) are believed to exert their antidiabetic effects via different mechanisms. As evidence suggests that both impair cell respiration in vitro, this study compared their effects on mitochondrial functions. The activity of complex I of the respiratory chain, which is known to be affected by metformin, was measured in tissue homogenates that contained disrupted mitochondria. In homogenates of skeletal muscle, metformin and TZDs reduced the activity of complex I (30 mmol/l metformin, −15 ± 2%; 100 μmol/l rosiglitazone, −54 ± 7; and 100 μmol/l pioglitazone, −12 ± 4; P < 0.05 each). Inhibition of complex I was confirmed by reduced state 3 respiration of isolated mitochondria consuming glutamate + malate as substrates for complex I (30 mmol/l metformin, −77 ± 1%; 100 μmol/l rosiglitazone, −24 ± 4; and 100 μmol/l pioglitazone, −18 ± 5; P < 0.05 each), whereas respiration with succinate feeding into complex II was unaffected. In line with inhibition of complex I, 24-h exposure of isolated rat soleus muscle to metformin or TZDs reduced cell respiration and increased anaerobic glycolysis (glucose oxidation: 270 μmol/l metformin, −30 ± 9%; 9 μmol/l rosiglitazone, −25 ± 8; and 9 μmol/l pioglitazone, −45 ± 3; lactate release: 270 μmol/l metformin, +84 ± 12; 9 μmol/l rosiglitazone, +38 ± 6; and 9 μmol/l pioglitazone, +64 ± 11; P < 0.05 each). As both metformin and TZDs inhibit complex I activity and cell respiration in vitro, similar mitochondrial actions could contribute to their antidiabetic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The clinically used drugs with known PGC-1α-modulating activity, such as fibrates, thiazolidinediones, metformin, and statins, display neurotoxicity and a limited ability to cross the blood–brain barrier (BBB) [35,36,37,38].”
From Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis (2021) · cites this paper as [36]
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,178
Fryer, L. G. D., Patel, A. P., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,035
Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973
Mu, J., Brozinick, J. T., Valladares, O., Bucan, M., & Birnbaum, M. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00251-9 · Cited by 924
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806
Cited by
Sorted by citations
Items 401–500 of 524
Li, Y., Park, J., Wu, Y., Cui, J., Jia, N., xi, M., & Wen, A. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.3.279 · Cited by 8
Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart
Heinz, S., Freyberger, A., Lawrenz, B., Schladt, L., Schmuck, G., & Ellinger-Ziegelbauer, H. C. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02519-1 · Cited by 8
New Regulator for Energy Signaling Pathway in Plants Highlights Conservation Among Species
Meyer, A. K., Longin, C. F. H., Klose, C. D., & Hermann, A. (2010) · Science Signaling · doi:10.1126/scisignal.3119jc5 · Cited by 8
Ramos, S. V., Distéfano, G., Lui, L., Cawthon, P. M., Kramer, P. A., SIPULA, I. J., Bello, F. M., Mau, T., Jurczak, M. J., Molina, A. J. A., et al. (2024) · Diabetes · doi:10.2337/db23-0827 · Cited by 7
Muller, C., Lacroix-Malgras, V., Kluza, J., Laine, W., Güler, Y., Bost, F., Boisbrun, M., Mazerbourg, S., & Flament, S. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03319-z · Cited by 7
Radioprotective effect of the anti-diabetic drug metformin
Siteni, S., Barron, S., Luitel, K., & Shay, J. W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307598 · Cited by 10
Resistance to Obesity in SOD1 Deficient Mice with a High-Fat/High-Sucrose Diet
Sato, A., Shiraishi, Y., Kimura, T., Osaki, A., Kagami, K., Ido, Y., & Adachi, T. K. (2022) · Antioxidants · doi:10.3390/antiox11071403 · Cited by 7
Bubak, M. P., Davidyan, A., O’Reilly, C. L., Mondal, S. A., Keast, J., Doidge, S. M., Borowik, A., Taylor, M. E., Volovičeva, E., Kinter, M. T., et al. (2024) · Aging Cell · doi:10.1111/acel.14235 · Cited by 6
Does glucose infusion exacerbate metformin-associated lactate acidosis? A case report
Brouwers, M. C. G. J., Schaper, N. C., & Keeris, L. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.010 · Cited by 7
Vecchio, S., Papa, P., & Protti, A. (2011) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-18081-1_60 · Cited by 7
Yuan, H., Weng, C., Yang, Y., Huang, L., & Xing, X. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.014 · Cited by 6
Mitochondrial Metabolism and Insulin Action
Turner, N. A. (2013) · InTech eBooks · doi:10.5772/56449 · Cited by 8
Brunmair, B., Staniek, K., Lehner, Z., Dey, D., Bolten, C. W., Stadlbauer, K., Luger, A., & Fürnsinn, C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2010 · Cited by 6
Self-citationWSF-P-1, a novel AMPK activator, promotes adiponectin multimerization in 3T3-L1 adipocytes
Wang, Y., Zhang, Y., Wang, Y., Han, P., Jian, R., Zhang, Z., Wang, S., & Li, Z. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1336923 · Cited by 6
Modulation of Cardiomyocyte and Hepatocyte Bioenergetics by Biguanides
Almarzooqi, S. S. (2014) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000203 · Cited by 6
Dykens, J. A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00071-7 · Cited by 6
Kjøbsted, R., Kristensen, J. M., Birk, J. B., Eskesen, N. O., Kido, K., Andersen, N. R., Larsen, J. K., Foretz, M., Viollet, B., Nielsen, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.22.492936 · Cited by 6
Thiazolidinediones Cause Cardiotoxicity via PPARγ- Independent Mechanism
Jiang, J., Balschi, J. A., McGowan, F. X. J., & He, H. (2018) · InTech eBooks · doi:10.5772/intechopen.78957 · Cited by 6
Advances in natural small molecules on pretranslational regulation of gluconeogenesis
Wu, X., & Chen, S. (2023) · Drug Development Research · doi:10.1002/ddr.22053 · Cited by 5
Enhanced Outcomes in Type 2 Diabetes Patients With Acute Kidney Disease Through Thiazolidinedione
Chang, L., Liao, H., Chen, J., & Wu, V. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae796 · Cited by 5
Mitochondria as a Biosensor for Drug-induced Toxicity – Is It Really Relevant?
Oliveira, Moreira, A. C., Machado, N. J., Bernardo, T. C., & Sardão, V. A. (2011) · InTech eBooks · doi:10.5772/17805 · Cited by 5
Possible modulation of the antidiabetic effect of rosiglitazone by buspirone
Mohamed, W. R., Sherbiny, G. A. E., Zaki, H. F., & Sayed, M. E. E. (2012) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2012.04.001 · Cited by 5
Kim, B., Lee, J., Shin, J. S., Suh, J.-W., Jung, S., Hwang, G., Lee, H., & Lee, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02729-7 · Cited by 5
Potential Benefits of Glitazones for Cancer and Vascular Disease
Pérez-Ortiz, J., Llorens, S., Llopis, J., Tranque, P., & Nava, E. (2008) · Current Drug Therapy · doi:10.2174/157488508784221271 · Cited by 4
Ferrick, D. A., Wu, M., Swift, A. L., & Neilson, A. (2008) · doi:10.1002/9780470372531.ch14 · Cited by 5
Li, J., Song, J., Yan, B., Wu, H., Banerjee, M., Magnuson, L., Liu, Y., Zhang, S., Liu, J., Wang, C., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01461-w · Cited by 4
Mitochondrial bioenergetics deficiency in cisd-1 mutants is linked to AMPK-mediated lipid metabolism
Hsiung, K. C., Tang, H.-Y., Cheng, M., Hung, L., Tan, B. C., & Lo, S. J. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100806 · Cited by 4
Pioglitazone Attenuates Acute Cocaine Toxicity in Rat Isolated Heart
Weinberg, G. L., Ripper, R. L., Bern, S., Lin, B., Edelman, L. B., DiGregorio, G., Piano, M. R., & Feinstein, D. L. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318218a7f6 · Cited by 4
Cerebrovascular Disease in Type 1 Diabetes: Role of Oxidative Stress
Arrick, D. M., & Mayhan, W. G. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4899-8035-9_2 · Cited by 4
Chronic metformin intake improves anaerobic but not aerobic capacity in healthy rats
de Araújo, G. G., LEARSI, S. K., Bastos‐Silva, V. J., Ataíde, T. D. R., & Lima‐Silva, A. E. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0459 · Cited by 4
Wei, F., Su, T., Wang, D., Li, H., & You, J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126746 · Cited by 4
Modifications of Mitochondrial Function by Toxicants☆
Maruf, A. A., Lee, O., & O’Brien, P. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.01900-0 · Cited by 4
Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium
Luse, M. A., Heiston, E. M., Malin, S. K., & Isakson, B. E. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200721002735 · Cited by 4
Mitochondrial function in skeletal muscle in type 2 diabetes.
Rabøl, R. (2011) · PubMed · Cited by 4
Activation of 5′AMP-activated protein kinase in skeletal muscle by exercise and phytochemicals
Egawa, T., Tsuda, S., Oshima, R., Goto, K., & Hayashi, T. (2014) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.3.55 · Cited by 3
Metabolomic analysis of survival in carbohydrate pre-fed pigs subjected to shock and polytrauma
Witowski, N. E., Lusczek, E. R., Determan, C. E., Lexcen, D. R., Mulier, K. E., Wolf, A., Ostrowski, B. G., & Beilman, G. J. (2016) · Molecular BioSystems · doi:10.1039/c5mb00637f · Cited by 3
Ran, S., Abeti, R., & Giunti, P. (2017) · Frontiers in diabetes · doi:10.1159/000454745 · Cited by 3
Preclinical testing of potential therapeutics for Amyotrophic Lateral Sclerosis
Kaneb, H. (2012) · Spiral (Imperial College London) · doi:10.25560/9606 · Cited by 3
Zohora, F. T., Mou, S. S., Haque, M. R., Baidya, M., Jahan, I., & Al-Mamun, M. E. (2025) · Translational Medicine of Aging · doi:10.1016/j.tma.2025.08.005 · Cited by 2
Wang, Y., Li, J., Zhu, L. L., Wu, Y., Su, Y. G., & Si, T. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03732-y · Cited by 4
Maintaining Energy Balance in Health and Disease: Role of the AMP-Activated Protein Kinase
Scott, J. W. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6382-6_9 · Cited by 2
Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle
Skrobuk, P., Kuoppamaa, H., Hiukka, A., & Koistinen, H. A. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.016 · Cited by 2
TorS ‐ Reframing a rational for type 2 diabetes treatment
Bar‐Tana, J. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3712 · Cited by 2
Jiang, Y., Chen, J., Du, X., Xiao, L., Jiang, H., Wang, F., & Wang, B. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143699 · Cited by 2
RetractedPPAR–gamma: a dagger in endometriosis
Amberkar, M. B. (2010) · Australasian Medical Journal · doi:10.4066/amj.2010.261 · Cited by 2
Angiogenesis, Arteriogenesis, and Mitochondrial Dysfunction
McMurtry, M. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5930-9_15 · Cited by 2
Chebor, O. O. N. M. K. (2020) · African Journal of Health Sciences · Cited by 2
Pioglitazona. Revisión de sus efectos metabólicos y sistémicos
Bernardino, Á. R., Blanco, S. C., & García, S. D. (2005) · Revista Clínica Española · doi:10.1016/s0014-2565(05)72655-2 · Cited by 2
Hoek, J. B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.033 · Cited by 2
Modulación de la expresión del gen MTND4 mitocondrial mediada por la actividad del CFTR.
Valdivieso, Á. G. (2009) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires) · doi:10.13140/rg.2.2.18182.78407 · Cited by 2
[Metformin-induced lactic acidosis : Severe symptoms with difficult diagnostics].
So, D., Wortmann, M., Siegler, B. H., Ulrich, A. G., Hofer, S., & Brenner, T. (2015) · PubMed · doi:10.1007/s00101-015-0017-7 · Cited by 1
EVOLUTION OF METFORMIN IN BREAST CANCER THERAPY IN LAST TWO DECADES: A REVIEW
Sarathi, R., Sarumathy, S., & Mavalavan, V. M. D. (2024) · Experimental Oncology · doi:10.15407/exp-oncology.2024.03.185 · Cited by 1
Song, L., Wang, R., Cui, J., Hu, S., Wang, J., Xie, J., Miao, P., & Sun, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1650805 · Cited by 2
MISRA, S., Deb, T., Devi, S., Singh, A., & Goel, R. (2026) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2025-0201 · Cited by 1
Receptor-Independent Metabolic Effects of Thiazolidinediones in Astrocytes
Akar, C. A., Kalinin, S., Gavrilyuk, V., Spagnolo, A., Weinberg, G. L., & Feinstein, D. L. (2010) · The Open Cancer Immunology Journal · doi:10.2174/1876401001003010036 · Cited by 1
Braveboy-Wagner, J. S. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/eg7w-qc88 · Cited by 1
Holmes, C., Powell, L., Clarke, N. S., Jessen, M. E., & Peltz, M. (2017) · Surgery · doi:10.1016/j.surg.2017.10.020 · Cited by 1
Obesity in the Pathophysiology of Diabetes
Paniagua, J. A., & Vidal‐Puig, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_14 · Cited by 1
23 cases of Metformin-induced Metabolic Lactic Acidosis in Patients treated with Metformin
Kubát, K., Zbořil, M., Semrádová, M., & Kaňák, V. (2017) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2017.015 · Cited by 1
AMPK Regulation of Cardiac Metabolism in Heart Disease
An, D., Kim, M., & Rodrigues, B. B. (2008) · Springer eBooks · doi:10.1007/978-0-387-09552-3_21 · Cited by 1
Glucose sensing and the regulation of the AMP-activated protein kinase in yeast
Rubenstein, E. M. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Pharmacological interventions part IV: Metabolic modifiers
Koltai, T., Reshkin, S. J., & Harguindey, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819059-3.00016-2 · Cited by 1
AMP-activated protein kinase as a therapeutic target for diabetes
Leff, T. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.08.002 · Cited by 1
LKB1/AMPK pathway in the control of hepatic energy metabolism
Viollet, B., & Foretz, M. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch23 · Cited by 1
Piel, S. (2018) · Lund University Publications (Lund University) · Cited by 1
Duran, J. M. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Metformin and/or Exercise Training Affect Metabolic Health in Men and Women with Prediabetes
Malin, S. K. (2011) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · doi:10.7275/2175194
Anedda, A. (2010) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Biomarkers of in Vitro Drug‐Induced Mitochondrial Dysfunction
Dykens, J. A., & Will, Y. (2010) · Biomarkers · doi:10.1002/9780470918562.ch16
The role of AMP-activated protein kinase in endothelial VEGF signalling
Reihill, J. A. (2009) · Enlighten: Theses (The University of Glasgow)
A global approach to dissecting lipid-induced impairment of liver gluconeogenesis
Hayward, B. J. (2013)
Impacte Metabòlic de l'Activació de la Glicogen Sintasa Hepàtica
Dominguez, S. R. (2009) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Introduction to Mitochondrial Toxicity
Will, Y., & Dykens, J. A. (2009) · Wiley eBooks · doi:10.1002/9780470744307.gat021
Regulation of metabolism and inflammation in liver and skeletal muscle
Nerstedt, A. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Moleculair werkingsmechanisme van metformine: oude of nieuwe inzichten?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-013-0061-3
RATLARDA ROZİGLİTAZON’UN TELOMER DİNAMİĞİNE ETKİSİNİN MOLEKÜLER YÖNTEMLERLE ARAŞTIRILMASI
Okuyucu, A., Bedir, A., & Özmen, Z. C. (2011) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.28.04.008
Effects of metformin on human monocytic THP-1 cells - Implications for type 2 diabetes mellitus
Tsuei, A.-C. (2010) · Research Commons (University of Waikato)
Boyle, J. G. (2009) · Enlighten: Theses (The University of Glasgow)
Lamontagne, J., Jalbert-Arsenault, É., Pépin, É., Peyot, M., Nolan, C. J., Joly, E. C., Madiraju, S. R. M., Poitout, V., & Prentki, M. (2013)
Weisová, P., Pfeiffer, S., & Prehn, J. H. M. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch5
Estudio de la expresión del gen CISD1 mediada por la actividad del CFTR
Taminelli, G. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Journal of Experimental and Clinical Medicine Deneysel ve Klinik Tip Dergisi
Okuyucu, A., Bedir, A., Özmen, Z. C., & Biyokimya, T. D. H. (2012)
Nitrosative Stress in Diverse Multisystem Diseases
Freye, E. C. K. (2011) · Springer eBooks · doi:10.1007/978-94-007-2036-7_7
Schofield, C. J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
St-Amand, E. (2015) · Corpus Université Laval (Université Laval)
SYSTEMIC DNA DAMAGE RESPONSE AND METABOLIC SYNDROME
Erol, A. (2010)
Dite, T. A. (2018) · Minerva Access (University of Melbourne)
Mechanisms of exercise intolerance in chronic heart failureand type 2 diabetes mellitus
Garnham, J. O. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Obesity in the Pathophysiology of Diabetes
Paniagua, J. A., & Vidal‐Puig, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_13
Coordinate control of metabolic flux with liver energy status by AMPK in vivo
Hasenour, C. M. (2014)
Pioglitazone, NEET Family Proteins, and Galactose Modulation of Liver Cell Bioenergetics
Grimm, D. F. (2017) · The Keep (Eastern Illinois University)
The role of mTOR signalling in translational control and cancer
Dowling, R. J. O. (2009) · eScholarship@McGill (McGill) · doi:10.82308/32572
Metformin severely impairs in vivo muscle oxidative capacity in a rat model of type 2 diabetes
Wessels, B., Čiapaitė, J., Nicolay, K., & Prompers, J. J. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.06.220
AMP-Activated Protein Kinase in Liver
Hue, L., Bultot, L., & Rider, M. H. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_18
Current literature in diabetes
(2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.534
Kettenhofen, R. F., & Schwengberg, S. (2010) · doi:10.1002/9780470915110.ch6
Solis-Herruzo, J. A., & García‐Ruíz, I. (2007) · Hepatology · doi:10.1002/hep.22045
Metadata
- Authors
- Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., & Fürnsinn, C.
- Affiliations
- University of Vienna (AT)
- University of Veterinary Medicine Vienna (AT)
- Universität Innsbruck (AT)
- Department of Medicine III, Division of Endocrinology & Metabolism, University of Vienna, Vienna, Austria
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2004-04-01
- Volume
- 53
- Issue
- 4
- Pages
- 1052-1059
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2403578638
- Cited by
- 521
- References
- 39
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 15 · 2023: 10 · 2022: 14 · 2021: 15 · 2020: 33 · 2019: 25 · 2018: 16 · 2017: 27 · 2016: 37 · 2015: 30 · 2014: 40 · 2013: 33 · 2012: 29
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Austrian Science Fund
- Universität Wien
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- thiazolidinediones, metformin, mitochondrial complex I, mitochondrial respiration, rosiglitazone, pioglitazone, skeletal muscle, anaerobic glycolysis, glucose oxidation, lactate release, antidiabetic mechanism, type 2 diabetes
- MeSH terms
- Rosiglitazone, Pioglitazone, Animals, Energy Metabolism, Hypoglycemic Agents, Male, Metformin, Mitochondria, Oxygen Consumption, Potassium Chloride, Rotenone, Rats, Sprague-Dawley, Muscle, Skeletal, Electron Transport Complex I, Thiazolidinediones, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review